Laekna, Inc. (HK:2105) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...
The Californian company earlier announced positive data at 52 weeks in a double-blind, dose-ranging Phase II study with ...
Bengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback